News › Clinical Practice, Industry News, Patient Care

Sculptra and Restylane Deliver 9-Month Skin, Confidence Boost Post-medication Weight Loss

August 1, 2025

Galderma recently announced final nine-month results from its phase 4 clinical trial confirming that the combination of Sculptra and Restylane Lyft or Contour delivers sustained improvement in facial appearance and high patient satisfaction for individuals facing aesthetic changes due to medication-driven weight loss.

The results, said clinical trial investigator Michael Somenek, MD, represent an evolution in how the aesthetics field can holistically support patients through their weight loss journey, both physically and emotionally.

Read more at Dermatology Times >>

 

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • PDGF, Regenerative Medicine and the Questions Med Spas Can’t Ignore
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • DAW Systems Earns First Artificial Intelligence Accreditation from DirectTrust
    • Estée Lauder Executive’s Death Linked to Pulmonary Embolism Following Cosmetic Filler Injection
Advertisement